Fosun’s top management at its 2017 interim results presentation in Hong Kong last month. The company has faced scrutiny from mainland authorities over its aggressive overseas acquisitions. Photo: K.Y. Cheng Fosun’s top management at its 2017 interim results presentation in Hong Kong last month. The company has faced scrutiny from mainland authorities over its aggressive overseas acquisitions. Photo: K.Y. Cheng
Fosun’s top management at its 2017 interim results presentation in Hong Kong last month. The company has faced scrutiny from mainland authorities over its aggressive overseas acquisitions. Photo: K.Y. Cheng

Fosun unit Sisram Medical seeks US$200 million in Hong Kong share listing

The maker of medical lasers will sell shares in Hong Kong and other markets in a move seen by analysts as part of the Fosun group’s plan to reduce its overall debt burden

Topic |   Banking & finance
Fosun’s top management at its 2017 interim results presentation in Hong Kong last month. The company has faced scrutiny from mainland authorities over its aggressive overseas acquisitions. Photo: K.Y. Cheng Fosun’s top management at its 2017 interim results presentation in Hong Kong last month. The company has faced scrutiny from mainland authorities over its aggressive overseas acquisitions. Photo: K.Y. Cheng
Fosun’s top management at its 2017 interim results presentation in Hong Kong last month. The company has faced scrutiny from mainland authorities over its aggressive overseas acquisitions. Photo: K.Y. Cheng
READ FULL ARTICLE